Centessa Pharmaceuticals plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Centessa Pharmaceuticals plc - ADR: Is Infosys Ltd. worth buying?
Item: Centessa Pharmaceuticals plc - ADR
Rating: 1.50333325
Author: Trendlyne DVM scores

about

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arter...

15.73 -0.06 (-0.38%)

63.85% Gain from 52W Low

950.2K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Centessa Pharmaceuticals plc - ADR is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details

Not Eligible

Expensive Valuation

5.8 / 100

Technically Neutral

54.3 / 100

1Yr Price target upside is 93%

7 analysts

Centessa Pharmaceuticals plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Centessa Pharmaceuticals plc - ADR Live Stock Price Today, Share Analysis and Chart

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arter...

63.85% Gain from 52W Low

SWOT Analysis

Centessa Pharmaceuticals plc Live Price Chart